Foundation Resource Management Inc. purchased a new position in Nutrien Ltd. (NYSE:NTR - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 173,060 shares of the company's stock, valued at approximately $7,744,000. Nutrien makes up 1.3% of Foundation Resource Management Inc.'s holdings, making the stock its 27th largest holding.
A number of other institutional investors and hedge funds have also bought and sold shares of the business. Wealth Enhancement Advisory Services LLC grew its stake in Nutrien by 6.5% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 4,309 shares of the company's stock valued at $207,000 after acquiring an additional 263 shares in the last quarter. Meixler Investment Management Ltd. grew its position in shares of Nutrien by 4.2% during the third quarter. Meixler Investment Management Ltd. now owns 7,159 shares of the company's stock valued at $344,000 after purchasing an additional 288 shares in the last quarter. Atria Investments Inc increased its holdings in shares of Nutrien by 2.0% in the third quarter. Atria Investments Inc now owns 14,636 shares of the company's stock worth $703,000 after purchasing an additional 290 shares during the last quarter. Mercer Global Advisors Inc. ADV lifted its position in shares of Nutrien by 8.3% in the second quarter. Mercer Global Advisors Inc. ADV now owns 4,660 shares of the company's stock worth $237,000 after buying an additional 356 shares in the last quarter. Finally, Kingsview Wealth Management LLC lifted its position in shares of Nutrien by 3.3% in the third quarter. Kingsview Wealth Management LLC now owns 11,317 shares of the company's stock worth $544,000 after buying an additional 365 shares in the last quarter. 63.10% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
NTR has been the topic of a number of research reports. Raymond James raised Nutrien from a "market perform" rating to an "outperform" rating and lifted their price objective for the stock from $58.00 to $60.00 in a research note on Tuesday, December 3rd. CIBC reissued an "outperformer" rating and issued a $55.00 target price (down from $60.00) on shares of Nutrien in a report on Tuesday, December 10th. Oppenheimer began coverage on shares of Nutrien in a research note on Thursday, December 12th. They set an "outperform" rating and a $60.00 price target on the stock. JPMorgan Chase & Co. raised shares of Nutrien from an "underweight" rating to a "neutral" rating and lifted their price objective for the stock from $40.00 to $50.00 in a research note on Monday. Finally, Piper Sandler upgraded shares of Nutrien from an "underweight" rating to an "overweight" rating and upped their target price for the company from $50.00 to $58.00 in a research report on Monday. One analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $59.21.
Read Our Latest Report on NTR
Nutrien Trading Up 0.8 %
Shares of NYSE:NTR traded up $0.39 on Wednesday, hitting $52.08. 2,280,037 shares of the company's stock were exchanged, compared to its average volume of 2,516,826. The stock has a market capitalization of $25.64 billion, a price-to-earnings ratio of 34.95, a price-to-earnings-growth ratio of 1.73 and a beta of 0.81. Nutrien Ltd. has a 12 month low of $43.69 and a 12 month high of $60.87. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The business's 50 day simple moving average is $46.90 and its two-hundred day simple moving average is $47.85.
Nutrien (NYSE:NTR - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.04). The company had revenue of $5.35 billion during the quarter, compared to analysts' expectations of $5.26 billion. Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The company's quarterly revenue was down 5.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.35 EPS. Analysts anticipate that Nutrien Ltd. will post 3.5 EPS for the current fiscal year.
Nutrien Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, January 17th. Investors of record on Tuesday, December 31st will be issued a $0.939 dividend. This is a positive change from Nutrien's previous quarterly dividend of $0.54. The ex-dividend date is Tuesday, December 31st. This represents a $3.76 dividend on an annualized basis and a dividend yield of 7.21%. Nutrien's payout ratio is presently 144.97%.
Nutrien Company Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Recommended Stories
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.